GPX4 and hypertensive disorder: The peptides activated the Nrf2-dependent antioxidant defense mechanism, which prompted the expression of endogenous antioxidant proteins (SOD1, SOD2, PRDX2, HO-1, and GSH-Px4). They also alleviated hypertension through DJ-1 and AKT signaling pathways.